Provided by Tiger Fintech (Singapore) Pte. Ltd.

Renaissance Technologies Holdings

1,658.31
-50.8456-2.97%
Number of Gainers:18
Number of Losers:78
Number of Flat:- -
PE:- -
High:1,706.57
Open:1,706.57
Low:1,651.25
Close:1,709.44
Loading ...

Applied Underwriters spins off United Risk into standalone entity

Reuters
·
Yesterday

Netflix Likely Unphased by Any Economic Downturn -- Market Talk

Dow Jones
·
Yesterday

United Therapeutics Corp : Bofa Global Research Raises to Neutral From Underperform

THOMSON REUTERS
·
Yesterday

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2025-04-21

Reuters
·
Yesterday

Supreme Court Denies CSX Bid to Revive Antitrust Suit Against Norfolk Southern

MT Newswires Live
·
Yesterday

CrowdStrike Trades at Premium Valuation: Buy, Sell or Hold the Stock?

Zacks
·
Yesterday

Here's Why Investors Should Give Greenbrier Stock a Miss Now

Zacks
·
Yesterday

Netflix Maintains Industry Lead as Competitors Unlikely to Catch Up, Wedbush Says

MT Newswires Live
·
Yesterday

Bausch (BHC) Moves 13.3% Higher: Will This Strength Last?

Zacks
·
Yesterday

Jim Cramer Calls Colgate-Palmolive Company (CL) a Recession-Resistant Winner

Insider Monkey
·
Yesterday

Gilead ASCENT-04 data a ‘welcome surprise,’ says Oppenheimer

TIPRANKS
·
Yesterday

Netflix Inc : Macquarie Raises Target Price to $1,200 From $1,150

THOMSON REUTERS
·
Yesterday

Market Chatter: European Commission President Asks X, Meta, TikTok to Comply With EU Digital Rulebook

MT Newswires Live
·
Yesterday

Cytokinetics reiterated as top pick at H.C. Wainwright, Camzyos updates positive

TIPRANKS
·
Yesterday

Johnson & Johnson announces new data from oncology pipeline at AUA meeting

TIPRANKS
·
Yesterday

Unusually active option classes on open April 21st

TIPRANKS
·
Yesterday

Netflix Shares up 3.3% After Q1 Results Beat

THOMSON REUTERS
·
Yesterday

Brokers Suggest Investing in Palo Alto (PANW): Read This Before Placing a Bet

Zacks
·
Yesterday

Netflix Beats Estimates, Eyes Ad Growth as Q2 Outlook Impresses

GuruFocus.com
·
Yesterday

Sanofi & Regeneron's Dupixent Receives FDA Nod for Urticaria

Zacks
·
Yesterday